SCHEMBL9148917

SCHEMBL9148917

O=C(O)C(Cc1ccccc1-c1ccccc1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 1.00
DPP4 P27487 1/20 0.50
MME P08473 1/20 0.50
ACE P12821 1/20 0.50
CPA1 P15085 1/20 0.50
ACE2 Q9BYF1 1/20 0.50
FOLH1 Q04609 1/20 0.49
KCNA5 P22460 2/20 0.47
KCNH2 Q12809 1/20 0.47
PPARA Q07869 4/20 0.47
PPARG P37231 2/20 0.47
PTGER1 P34995 2/20 0.45
PTGER4 P35408 2/20 0.45
PTGER3 P43115 2/20 0.45
PTGER2 P43116 2/20 0.45
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
HNF4A P41235 1/20 0.44
MAPK1 P28482 1/20 0.43
BCAT2 O15382 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171071 0.83 KMT2A (0.71) KMT2ADPP4PDCD1CD274MAPK1
SCHEMBL6724651 0.83 KMT2A (0.71) KMT2ADPP4MMEACECPA1
SCHEMBL19667642 0.83 KMT2A (0.71) KMT2ADPP4PDCD1CD274MAPK1
SCHEMBL16967410 0.83 KMT2A (0.71) KMT2ADPP4PDCD1CD274MAPK1
SCHEMBL3149585 0.83 KMT2A (0.71) KMT2ADPP4MMEACECPA1
SCHEMBL23189270 0.83 KMT2A (0.71) KMT2ADPP4MMEACECPA1
Hydrochloric Acid SCHEMBL6721519 0.82 KMT2A (0.69) KMT2ADPP4MMEACECPA1
Bicarbonate SCHEMBL27541289 0.81 KMT2A (0.68) KMT2ADPP4MMEACECPA1
SCHEMBL28303450 0.81 KMT2A (0.68) KMT2ADPP4MMEACECPA1
SCHEMBL1582615 0.80 KMT2A (0.67) KMT2ADPP4MMEACECPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150328329-A1 LIGANDS THAT TARGET HCV-E2 BINDING SITES ON CD81 AND THERAPEUTIC METHODS USING THEM American University of Cairo (EG) 2015-11-19 US disclosed
WO-2014081856-A2 LIGANDS THAT TARGET HCV-E2 BINDING SITES ON CD81 AND THERAPEUTIC METHODS USING THEM AZZAZY HASSAN (EG) 2014-05-30 WO disclosed
US-5384069-A Alignment stability, fine and high speed display CANON KABUSHIKI KAISHA (JP) 1995-01-24 US disclosed
EP-0292244-B1 POLYMERIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE CANON KABUSHIKI KAISHA (JP) 1993-08-11 EP disclosed
EP-0292244-A2 Polymeric liquid crystal composition and liquid crystal device CANON KABUSHIKI KAISHA (JP) 1988-11-23 EP disclosed
US-4429149-A PYRETHRUM-RELATED INSECTICIDES FMC CORPORATION (US) 1984-01-31 US disclosed
US-4346251-A 4-Substituted-2-indanols FMC CORPORATION (US) 1982-08-24 US disclosed
US-4335252-A A4-PHENYL-Z-INDANYL CYCLOPROPANE CARBOXYLATE FMC CORPORATION (US) 1982-06-15 US disclosed
US-4263319-A CYCLOPROPYL ESTERS FMC CORPORATION (US) 1981-04-21 US disclosed